Rickert, Daniel A.
Gómez-Ríos, German A.
Nazdrajić, Emir
Tascon, Marcos
Kulasingam, Vathany
Pawliszyn, Janusz B.
Funding for this research was provided by:
Natural Sciences and Engineering Research Council of Canada (Industrial Research Chair Program)
Article History
Received: 30 August 2019
Revised: 9 December 2019
Accepted: 19 December 2019
First Online: 6 January 2020
Compliance with ethical standards
:
: G.A. Gómez-Ríos and J.B. Pawliszyn are co-inventors of the coated blade spray (US patent: 9733234), while JP Scientific Limited holds ownership over this patent. The patent has now been licensed to Restek Corporation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. All authors claim no nonfinancial conflict of interest in the submitted manuscript.
: Human whole blood specimens were collected from patients undergoing immunosuppressant therapy at the University Health Network (UHN; Toronto, ON, Canada). Informed consent was obtained prior to specimen collection, and ethics approval was waived by the Research Ethics Board at UHN for use of routine-collected specimens for the evaluation of method performance.